相关实验视频
Updated: Jan 16, 2026

09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
1.8K
在急性呼吸窘迫综合征中膜上皮细胞功能障碍:机理性见解和有针对性的干预措施
1Department of Physiology, School of Medicine, Southeast University, Nanjing 210009, China.
Biomedicines
|September 27, 2025
概括
膜上皮细胞 (AEC) 功能障碍导致急性呼吸困扰综合征 (ARDS). 本综述探讨了AEC损伤机制和新兴的向疗法,包括基于基因的方法和微生物组调制,以改善ARDS治疗.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 再生医学是一种再生医学.
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 是一种严重的疾病,具有显著的死亡率.
- 膜上皮细胞 (AEC) 功能障碍是ARDS发病的一个关键因素,导致屏障破坏和炎症.
研究的目的:
- 审查ARDS中AEC损害的机制.
- 评估新兴的AEC向疗法和ARDS治疗的补充策略.
主要方法:
- 关于ARDS病原和AEC损伤的文献综合审查.
- 对单细胞测序和空间转录组学数据的分析.
- 对药理学,生物学和基因治疗方法的评估.
主要成果:
- 关键的AEC损伤机制包括编程细胞死亡,氧化应激,线粒体功能障碍,表观遗传变化和代谢重新连接.
- 多细胞交叉和肠肺轴显著影响ARDS的进展.
- 新兴疗法直接针对AEC或调节微生物组和免疫反应.
结论:
- 了解AEC功能障碍机制对于开发有效的ARDS疗法至关重要.
- 精准医学,微生物组调制和再生方法为ARDS治疗提供了有前途的途径.
- 克服转化障碍对于推进以表皮为中心的ARDS疗法至关重要.
相关概念视频
Acute Respiratory Failure-V
462
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
462
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Acute Respiratory Failure-I
855
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
855
Acute Respiratory Failure-III
788
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
788
Breathing
64.2K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K

